Scanvio Medical Raises $3.4M Seed Round to Fast‑Track Endometriosis Diagnosis with AI‑Augmented Ultrasound Technology

Scanvio Medical is thrilled to announce a major milestone in our growth journey, having successfully raised $3,400,000 in our latest funding round. This investment represents not only a vote of confidence in our innovative approach to healthcare but also a significant step forward in our mission to help millions of women receive faster, more accurate endometriosis diagnoses. With our cutting-edge AI-augmented ultrasound software, we empower every gynecologist with expert sonography skills – a breakthrough that has already begun reshaping the way women experience reproductive health diagnostics. The funds raised will be strategically allocated to further developing our technology, expanding our market presence, and enhancing our research and development initiatives. By investing in state-of-the-art AI capabilities and scalable platforms, we aim to streamline diagnostic processes and reduce the often frustrating delays faced by countless patients. Our commitment to precision medicine and accessible healthcare remains steadfast as we scale our operations, broaden our clinical partnerships, and reinforce our team with top-tier talent in medical technology and artificial intelligence research. This infusion of capital marks a decisive moment for Scanvio Medical, reaffirming our belief in a future where advanced diagnostic tools become a standard component in every gynecologist’s toolkit. We are excited to embark on this next chapter of growth, confident that our enhanced capabilities will lead to revolutionary improvements in patient care and outcomes, ultimately ushering in a new era of efficiency, accuracy, and hope for women battling endometriosis worldwide.